Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR(®) study

BACKGROUND: Patients with prior invasive fungal infection (IFI) increasingly proceed to allogeneic hematopoietic cell transplantation (HSCT), however, little is known about the impact of prior IFI on survival. METHODS: Patients with pre-transplant IFI (cases; n=825) were compared to controls (n=10,2...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Bone Marrow Transplant
Autores principales: Maziarz, Richard T., Brazauskas, Ruta, Chen, Min, McLeod, Aleksandra A., Martino, Rodrigo, Wingard, John R., Aljurf, Mahmoud, Battiwalla, Minoo, Dvorak, Christopher C., George, Biju, Guinan, Eva C., Hale, Gregory A., Lazarus, Hillard M., Lee, Jong-Wook, Liesveld, Jane L., Ramanathan, Muthalagu, Reddy, Vijay, Savani, Bipin N., Smith, Franklin O., Strasfeld, Lynne, Taplitz, Randy A., Ustun, Celalettin, Boeckh, Michael J., Gea-Banacloche, Juan, Lindemans, Caroline A., Auletta, Jeffery J., Riches, Marcie L.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5358320/
https://ncbi.nlm.nih.gov/pubmed/27991895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2016.259
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares